Changes proposed to Clinical Laboratories Improvement Amendments (CLIA) categories
This article was originally published in Clinica
Executive Summary
The US Health Care Financing Administration has published proposed clarified criteria for waived tests under the Clinical Laboratories Improvement Amendments. In order to be exempt from CLIA, all test systems must either be cleared by the FDA for home use or meet requirements to ensure the test procedure is "simple and not prone to error". While the agency has elaborated in the Federal Register (September 13th) properties it considers meet this description, it is interested in comments on alternatives.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.